Connecting AYA patients and survivors to open clinical trials Each year, about 85,000 adolescents and young adults (AYA) between the ages of 15 and 39 are diagnosed with cancer in the United States. According to the National Cancer Institute, this represents about 4% of all new cancer diagnoses. Depending on age and specific diagnosis, many…
A new clinical trial led by the Alliance for Clinical Trials in Oncology will investigate if a combination of drug therapies after radiation therapy improves outcomes for people with newly-diagnosed, grade 3 IDH-mutant astrocytoma, a type of brain cancer. Supported in part by a grant from the National Cancer Institute, the study (Alliance A072301) will…
At the Alliance for Clinical Trials in Oncology (Alliance), we share stories highlighting the progress and impact of cancer research. By shining a light on new clinical trials, scientific discoveries, and the achievements of our investigators, we showcase the progress being made against cancer and the people driving it forward. These stories raise awareness of…
At the Alliance for Clinical Trials in Oncology (Alliance), we share stories highlighting the progress and impact of cancer research. By shining a light on new clinical trials, scientific discoveries, and the achievements of our investigators, we showcase the progress being made against cancer and the people driving it forward. These stories raise awareness of…
At the Alliance, we share stories highlighting the progress and impact of cancer research. By shining a light on new clinical trials, scientific discoveries, and the achievements of our investigators, we showcase the progress being made against cancer and the people driving it forward. These stories raise awareness of the essential role clinical trials play…
Highlighting the progress and impact of cancer research, the Alliance shares stories about new clinical trials, scientific discoveries, and the achievements of our investigators. These features showcase the progress being made against cancer and the people driving it forward. By sharing these stories, we raise awareness of the vital role clinical trials play in improving…
Recent publications from Alliance investigators are delivering practice-changing insights that directly improve patient care. Featured in leading journals—including the New England Journal of Medicine, Journal of Clinical Oncology, and JAMA Oncology—these studies are shaping treatment strategies for prostate cancer, meningioma, lung cancer, and colon cancer. Below is a selection of these recent publications. Journal of…
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that abemaciclib, an oral cancer drug, may slow tumor growth in patients with aggressive meningiomas that have specific genetic mutations. This primary analysis of Alliance A071401 is published in Nature Medicine. Meningiomas, tumors that grow in the membranes that surround…